| View |
|
DRP-13673-03
|
Ampicillin (as sodium)
|
Eurozyllin 500
|
500 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Penicillin)
|
UNI Medicolabs, Inc.
|
India
|
CLIDP Conversion
|
16 November 2023
|
24 March 2028
|
| View |
|
DRP-13686-03
|
Losartan Potassium
|
Artrice 100
|
100 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
12 November 2023
|
28 March 2028
|
| View |
|
DRP-13687-03
|
Losartan Potassium
|
Artrice 50
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
02 November 2023
|
28 March 2028
|
| View |
|
DRP-13797-01
|
Tranexamic Acid
|
Hemoden
|
100 mg/mL (500 mg/5 mL)
|
Solution for Injection (IM/IV)
|
Anti-fibrinolytic
|
Farbe Firma
|
India
|
CLIDP Conversion
|
12 November 2023
|
02 May 2028
|
| View |
|
DRP-13911-01
|
Cefepime (as hydrochloride)
|
None
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
PT Darya-Varia Laboratoria Tbk
|
Indonesia
|
CLIDP Conversion
|
16 November 2023
|
14 March 2028
|
| View |
|
DRP-14325-01
|
Clonidine Hydrochloride
|
Clonisea
|
150 mcg / mL
|
Solution for Injection (I.V.)
|
Centrally Acting Antiadrenergic Agent
|
Kwality Pharmaceuticals Ltd.
|
India
|
CLIDP Conversion
|
16 November 2023
|
23 August 2028
|
| View |
|
DRP-2347-04
|
Ambroxol Hydrochloride
|
None
|
6 mg/mL
|
Syrup (Oral Drops)
|
Mucolytic
|
J.M. TOLMANN LABORATORIES INC
|
Philippines
|
CLIDP Conversion
|
16 November 2023
|
06 August 2026
|
| View |
|
DRP-2992-06
|
Colchicine
|
Unbranded
|
500 mcg
|
Tablet
|
Antigout
|
Inga Laboratories P. Ltd.
|
India
|
Renewal
|
29 March 2024
|
02 August 2029
|
| View |
|
DRP-3199-10
|
Telmisartan + Hydrochlorothiazide
|
Telchor
|
40 mg / 12.5 mg
|
Tablet
|
Angiotensin II Receptor Blocker/Diuretic
|
Theon Pharmaceuticals Ltd.
|
India
|
CLIDP Conversion
|
16 November 2023
|
23 August 2026
|
| View |
|
DRP-4974-01
|
Citicoline (as sodium)
|
Unbranded
|
250 mg / mL (1000 mg/4 mL)
|
Solution for Injection (IM/IV)
|
Nootropic
|
Akums Drugs & Pharmaceuticals Ltd. (Plant III Injectables)
|
India
|
Renewal
|
16 January 2024
|
17 June 2029
|
| View |
|
DRP-5051-03
|
Azithromycin (as dihydrate)
|
Aziqo
|
200 mg/5 mL
|
Powder for Suspension
|
Antibacterial (Macrolide)
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
02 November 2023
|
10 June 2028
|
| View |
|
DRP-5052-26
|
Cefixime (as trihydrate)
|
Rezef
|
100 mg/5 mL
|
Granules for Suspension
|
Antibacterial (Third Generation Cephalosporin)
|
J.M. TOLMANN LABORATORIES INC
|
Philippines
|
CLIDP Conversion
|
16 November 2023
|
18 August 2027
|
| View |
|
DRP-5683-23
|
CEFIXIME
|
CEFTRIKIDS
|
20 mg / mL
|
Granules for Suspension (Oral Drops)
|
ANTIBACTERIAL (CEPHALOSPORIN)
|
J.M. Tolmann Laboratories, Inc
|
Philippines
|
Renewal
|
01 March 2024
|
20 February 2029
|
| View |
|
DRP-11001-01
|
Lactulose
|
Laxipate
|
3.35 g/ 5 mL
|
Syrup (Caramel Flavor)
|
-
|
Azine Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 December 2023
|
31 December 2026
|
| View |
|
DRP-8837-02
|
Cefuroxime (as sodium)
|
Natricef
|
750 mg
|
Powder for Injection (I.M./I.V.)
|
-
|
NCPC Hebei Huamin Pharmaceutical Company Limited
|
China
|
CLIDP Conversion
|
29 April 2023
|
05 May 2025
|
| View |
|
DRP-5926-07
|
Cefixime (as Trihydrate)
|
Sefhix
|
100 mg / 5 mL
|
Powder for Suspension
|
Antibacterial (Cephalosporin)
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
07 November 2023
|
12 October 2026
|
| View |
|
DRP-6955-05
|
Meropenem (as trihydrate)
|
Zeronem
|
1 g
|
Powder for Injection (IV)
|
Antibacterial (Carbapenem)
|
BCWorld Healtchare Co., Ltd.
|
Korea
|
CLIDP Conversion
|
02 November 2023
|
04 January 2027
|
| View |
|
DRP-708-04
|
Salbutamol (as sulfate) + Guaifenesin
|
Kenzoplegm
|
1 mg/50 mg per 5 mL
|
Syrup
|
Bronchodilator/ Expectorant
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
06 November 2023
|
15 January 2029
|
| View |
|
DRP-736-06
|
Cefalexin (as Monohydrate)
|
Canexil
|
500 mg
|
Capsule
|
Antibacterial (Cephalosporin)
|
LifeSquare Laboratories, Inc.
|
Philippines
|
Renewal
|
24 September 2024
|
17 January 2030
|
| View |
|
DRP-7859-04
|
Meropenem (as trihydrate)
|
Zeronem 500
|
500 mg
|
Powder for Injection (IV)
|
Antibacterial (Carbapenem)
|
BCWorld Healthcare Co., Ltd
|
Korea
|
CLIDP Conversion
|
02 November 2023
|
31 May 2028
|